1Mby1M Virtual Accelerator AI Investor Forum: With Mo Islam, Partner at Threshold Ventures (Part 4)

Sramana Mitra: What is the situation vis-a-vis startup biotech companies that want to use a platform like Atomwise? Is Atomwise seeing startup biotech companies build on their platform?

Featured Videos

2025 Resolution: Achieve Fundability for Your Startup

As you know, I categorically support bootstrapped entrepreneurs.

There are numerous startups now that have achieved some revenue without any external funding.

However, it has taken time. Sometimes, it has taken 5-7 years to get there.

VCs, however, are looking for velocity.

Their goal is to achieve $100M in 5-7 years.

>>>

666th 1Mby1M Roundtable for Entrepreneurs Starting NOW: Live Tweeting by @1Mby1M

Today’s 666th FREE online 1Mby1M Roundtable for Entrepreneurs is starting NOW, on Thursday, December 19, at 8 a.m. PST / 11 a.m. EST / 5 p.m. CET / 9:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!         

Video FAQs

666th 1Mby1M Roundtable for Entrepreneurs Starting in 30 Minutes: Live Tweeting by @1Mby1M

Today’s 666th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 30 minutes, on Thursday, December 19, at 8 a.m. PST / 11 a.m. EST / 5 p.m. CET / 9:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

2025 Resolution: Achieve Acceleration with Your Startup

I have been running 1Mby1M since 2010.

Each year is a new beginning.

Let’s start 2025 right!

>>>

1Mby1M Virtual Accelerator AI Investor Forum: With Mo Islam, Partner at Threshold Ventures (Part 3)

Sramana Mitra: Could you talk a little bit about the financing journey of a company that has a 10-15 year lifecycle?

Cloud Stocks: MongoDB Focuses on AI Platform Development

MongoDB (NASDAQ: MDB) reported stellar third quarter results last week. However, sudden leadership changes and worries about a weak sequential growth sent the stock falling 8% in the after-hours session.

1Mby1M Virtual Accelerator AI Investor Forum: With Mo Islam, Partner at Threshold Ventures (Part 2)

Sramana Mitra: So let’s double click down on drug discovery. It’s something that I’ve been spending time on as well. What have you invested in and how are you thinking about AI-enabled drug discovery?

What’s the criteria of what you want to invest in and what have you invested in?